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Abstract
Quantifying the effects of cis-regulatory DNA on gene expression is a major challenge. Here, we 
present the multiplexed editing regulatory assay (MERA); a high-throughput CRISPR/Cas9-based 
approach that analyzes the functional impact of the regulatory genome in its native context. 
MERA tiles thousands of mutations across ~40 kb of cis-regulatory genomic space and uses 
knock-in green fluorescent protein (GFP) reporters to read out gene activity. Using this approach, 
we obtain quantitative information on the contribution of cis-regulatory regions to gene 
expression. We identify proximal and distal regulatory elements necessary for expression of four 
embryonic stem cell-specific genes. We show a consistent contribution of neighboring gene 
promoters to gene expression and identify unmarked regulatory elements (UREs) that control gene 
expression but do not have typical enhancer epigenetic or chromatin features. We compare 
thousands of functional and non-functional genotypes at a genomic location and identify the 
basepair-resolution functional motifs of regulatory elements.
Gene regulation provides the basis for cell type-specific function. Although differences in 
cis-regulatory DNA are known to underlie human variation and disease, predicting the 
effects of cis-regulatory variants on gene expression remains challenging.
Important strides have been made over the past decade to catalog gene regulatory elements. 
A histone modification code has been found to correlate with cis-regulatory elements, such 
as enhancers and promoters, and states, such as active and poised1–5. Gene expression 
reporter assays, which can now be done in high-throughput formats6–8, have confirmed 
elements that are sufficient to activate gene expression in heterologous contexts. 
Additionally, techniques to identify distal DNA interactions have begun to associate 
enhancers with their cognate promoters9–12, which are often not in close proximity and can 
at times be megabases apart.
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However, existing gene regulatory techniques have several shortcomings. Reporter assays 
focus on elements that are sufficient to activate gene expression in a heterologous context 
and therefore cannot characterize elements that are necessary but not sufficient for gene 
expression or elements whose activity does not transfer to a non-native context. 
Additionally, genes can have many regulatory elements, and there is no high-throughput 
approach capable of determining the relative importance of each gene regulatory element on 
native gene expression levels. Efforts to systematically test enhancers, predicted using 
histone modification data from reporter assays, have found that the majority of predicted 
enhancers do not activate gene expression as expected13. This suggests that additional assays 
are required to decipher native gene regulation.
CRISPR/Cas9 has been used in genome-wide mutation screens to identify genes required for 
survival, drug resistance and tumor metastasis24–28 In these screens, guide RNAs (gRNAs) 
targeting tens of thousands of sites within genes are cloned into lentiviral vectors and 
delivered as a pool into target cells along with Cas9. By identifying gRNAs that are enriched 
or depleted in the cells after selection for the desired phenotype, genes that are required for 
this phenotype can be systematically identified.
Here we develop CRISPR/Cas9-based MERA to analyze the regulatory genome at single 
base resolution in its native context. MERA employs Cas9, which has been shown to cleave 
DNA when paired with a single-gRNA14–17. In MERA, Cas9-induced double-strand breaks 
(DSBs) are repaired in an error-prone fashion by cellular non-homologous end joining 
(NHEJ), inducing a wide range of mutations initiated at the cleavage site which are typically 
small (<10 bp) insertion/deletions (indels) but can include larger (>100 bp) indels15, 16, 23 
and altered individual bases.
The MERA assay first carries out a high-throughput screen that maps the effects of genomic 
variation on gene expression. Selected elements can then be characterized by functional 
motif discovery and validated. We map elements that are required for gene expression by 
expressing gRNAs that tile a gene’s cis-regulatory region and measuring how likely each 
gRNA is to diminish gene expression. We then perform deep sequencing of the gRNA-
induced mutations in targeted regions to reveal thousands of genotypes that either did or did 
not lose gene expression. This enables us to characterize the functional importance of each 
base. Finally, we validate the results of the MERA screen by the replacement of selected 
genomic elements by homologous recombination.
Results
Developing the MERA assay
There are two distinctions between MERA and previous gene mutation screening 
approaches that spurred us to alter the CRISPR/Cas9-based mutation screening technique. 
First, the targeted sites in our screen are often close together, so cells receiving more than 
one gRNA may delete a region instead of mutate that region, which would complicate 
downstream analysis. While this issue can be addressed for lentiviral libraries by lowering 
the multiplicity of infection (MOI), we sought a more elegant approach to limit cells to a 
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single gRNA. Second, each gene for which we perform MERA requires a different gRNA 
library.
All high-throughput CRISPR/Cas9-based approaches to date have required cloning gRNA 
libraries into a lentiviral vector and producing a batch of virus, a time-consuming process 
that would have to be done separately for each library. We sought an approach that would 
allow a library to be used on the day it arrives.
To enable the efficient targeting of precisely one regulatory element per cell, we devised a 
strategy that ensures that only one gRNA can be expressed per cell and allows gRNA 
libraries to be used without any molecular cloning into a delivery vector. We integrated a 
single copy of the gRNA expression construct (a U6 promoter driving expression of a 
dummy gRNA hairpin) into the universally accessible ROSA locus of mouse embryonic 
stem cells (mESCs) using CRISPR/Cas9-mediated homologous recombination (Fig. 1a). We 
then use CRISPR/Cas9-mediated homologous recombination to replace the dummy gRNA 
with a gRNA from our library. We use PCR to add 79–90 bp homology arms to our gRNA 
library, as we found that longer homology arms increase background cutting of gRNAs 
transcribed from unintegrated PCR fragments (Supplementary Fig. 1). We then introduce the 
pool of gRNA homology fragments into cells along with Cas9 and a gRNA plasmid that 
induces a DSB at the dummy gRNA site. In a substantial fraction of cells (~30%), the 
dummy gRNA is repaired by homologous recombination, creating a functional gRNA 
expression construct targeting a single genomic site from the library (Fig. 1a, Supplementary 
Fig. 2). It is random chance which gRNA is integrated in each cell, allowing a pooled screen 
in which each cell expresses only one gRNA.
Of note, the genomic integration-based gRNA screening platform used in MERA could also 
be applied to other CRISPR-based high-throughput screens as long as the cell line undergoes 
homologous recombination at appreciable frequency, and it could be modified to achieve 
expression of any set number of gRNAs per cell for combinatorial screening. While the 
integration-based approach is thus ill-suited to in vivo screens or screens in cells with 
limited homologous recombination, it provides an alternative to lentiviral screening that 
substantially reduces the time, effort, and cost involved in CRISPR library screening for 
applicable cell lines such as ESCs.
We generated GFP knock-in lines for four mESC-specific genes, Nanog, Rpp25, Tdgf1, and 
Zfp4229, and synthesized corresponding gRNA libraries, each with 3908 gRNAs tiling cis-
regulatory regions. In case of Tdgf1, the library targeted the 40 kb region proximal to the 
gene in an unbiased manner. In other cases, we selected proximal regions to the gene most 
likely to be involved in regulation based on enhancer-like features that are a maximum of 
~150kb away from the gene as well as distal regions up to 92 mB away from the gene when 
ChIA-PET distal interaction data2 suggested a possible interaction with the target gene 
promoter3 (Supplementary Information). In Figures 2 and 3, the bulk density panel shows 
the distribution of integrated gRNAs along the region probed. Among the 3621 gRNAs 
found to be integrated in at least 1 replicate of Tdgf1, the mean distance between adjacent 
gRNAs was 11bp. Of note, repetitive and unmappable genomic regions cannot be tiled with 
gRNAs, and gRNAs targeting regions whose sequence differs from that of the reference 
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genome cannot be appropriately tiled without genome sequence data of the cell line. Each 
library also contained 10 positive control gRNAs targeting the GFP open reading frame that 
we expected would cause GFP loss.
MERA screens identify required regulatory regions
We performed four biological replicate screens for Zfp42 and Tdgf1, two replicates for 
Nanog and a single replicate for Rpp25. Selected screen hits were independently confirmed 
as described below. Starting one week after electroporation, we collected genomic DNA of 
the unsorted library-integrated cells to examine differences in gRNA integration. Over 90% 
of correctly synthesized gRNAs were detected in the genomic DNA for both Tdgf1 and 
Zfp42 libraries (Supplementary Methods). In addition, gRNA integration rates in biological 
replicates showed concordance (Fig. 1c,d; Supplementary Fig. 4a). All of the regulatory 
regions that we surveyed had adequate coverage of gRNAs to assay their detailed function 
(Bulk density track, Fig. 2,3; Supplementary Figure 5–6).
Library-integrated mESCs were then flow cytometrically sorted to identify gRNAs inducing 
loss of GFP expression. Separate GFPneg and GFPmedium populations were sorted in the 
Tdgf1GFP and Zfp42GFP experiments, whereas GFPneg and GFPmedium populations were 
combined in the NanogGFP and Rpp25GFP experiments because of incomplete population 
separation (Fig. 1b; Supplementary Fig. 3).
The distribution of gRNA abundance in GFPneg and GFPmedium populations in all screens 
clearly indicates that a subset of cis-regulatory genomic space is required for gene 
expression at all four gene loci (Fig. 2a,b, Fig. 3). We detected significant overrepresentation 
of nearly all integrated positive control GFP coding region targeting gRNAs in all replicates 
(Fig. 2d, Fig. 3c, Supplementary Fig. 4b) suggesting that MERA robustly identifies gRNAs 
inducing loss of gene expression. Using the relative abundances of GFP open reading frame 
(ORF)-targeting positive control gRNAs and the dummy gRNA as a negative control, we 
devised a method to detect gRNAs with statistically significant overrepresentation in GFPneg 
and GFPmedium populations (Supplementary Fig. 4b,c, Supplementary Methods).
In our MERA screen of Tdgf1 we observed differential enrichment of gRNAs in established 
functional categories of genomic elements associated with gene regulation33, 34353637 (Fig. 
2a,d, Supplementary Fig. 5). The highest density of significant gRNAs in the genomic 
regions were observed at the promoter region for Tdgf1, the strong proximal enhancer 4kb 
upstream of Tdgf1, and the strong enhancer overlapping the Lrrc2 promoter (Fig. 2a,d).
Surprisingly we observed a novel class of genomic elements downstream of Tdgf1 (Figure 
2a, highlighted in grey) which did not coincide with any known markers of regulatory 
activity such as H3K27ac, H3K4me1, H3K4me3, known transcription factor (TF) binding 
sites, DNase-I hypersensitivity, predicted DNase-I hotspots, or enhancers predicted from 
chromatin modifications. We designated such elements that do not contain these markers as 
unmarked regulatory elements (UREs). Unmarked regulatory regions were often over 1 kb 
in length and produced comparable loss of GFP as some distant enhancers (Fig. 2d).
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In our MERA screen of Zfp42, we also observed the strongest enrichment for GFP loss in 
the promoter and proximal enhancer regions (Fig. 3a,c). We observed enrichment of gRNAs 
in the GFPneg and GFPmedium population at UREs in regions II, III, VI and VII (Fig. 3a, 
Supplementary Fig. 6a) and observed the participation of the neighboring Trim12 promoter 
in regulating Zfp42 (Figure 3a, Supplementary Figure 6b). We also note that regulatory 
regions upstream of Zfp42 tended to cause intermediate loss of GFP as compared to a 
complete loss of GFP (GFPmedium in red versus GFPneg in blue; Fig. 3c), suggesting that 
these enhancers are each responsible for only part of the overall Zfp42 expression level in 
cells.
Validation of MERA hits
To determine the accuracy of the MERA screen in systematically determining required cis-
regulatory regions, we first examined replicate consistency among our Tdgf1, Zfp42, and 
Nanog MERA data. Spatial patterns of GFPneg gRNA enrichment were largely conserved 
between replicates with Pearson correlation values of 0.8 at 300 bp bin size (Fig. 2c, Fig. 3b, 
Supplementary Fig. 6c). At an individual level, the overlap between gRNAs enriched in 
GFPneg populations between replicates was significant for all replicates (hyper geometric p-
value <0.001); however, it was not as high as for binned regions, likely because a single 
gRNA can cause thousands of distinct mutant genotypes with varying phenotypes.
To analyze false positives caused by off-target effects, we examined how putative off-target 
effects affect MERA results using a model based on GUIDE-Seq38 (Supplementary 
Methods). We found that when we eliminate gRNAs with potential off-target effects from 
our analysis, the global distribution of significantly enriched gRNAs along the regulatory 
landscape of the gene is unaltered and relative contributions of different functional 
categories are unaffected (Supplementary Fig. 5a and 6a,c). Furthermore, several gRNAs 
with no predicted off-target effects support the regulation of Tdgf1 by the promoter of Lrrc2 
(Supplementary Fig. 5b), the promoter of Trim12, and a URE region (Supplementary Fig. 
6a–c), and none of these regions are more likely to contain off-target effects than other 
screened regions.
To analyze potential off-target effects with an independent method, we asked whether any 
gRNAs from the Tdgf1 library would extinguish Zfp42-GFP activity and vice versa. We 
found that a much smaller percentage of cells lose GFP upon targeting by a mismatched 
gRNA library than by the matched library (Supplementary Fig. 8). Sequencing revealed that 
the gRNAs enriched in GFPneg mismatched library-targeted cells were predominantly GFP 
control gRNAs with a small number of non-clustered gRNAs displaying off-target activity 
(Supplementary Figs 5,6). Thus, the clustered enrichment of GFP loss at enhancers, 
neighboring promoters, and UREs in MERA is not replicated by computationally predicted 
or experimentally determined off-target effects, leading us to conclude that GFP loss in these 
regions is a result off on-target gRNA effects (Supplementary Fig. 5a–c, Supplementary Fig. 
6a,b).
To determine the false-positive rate at the level of individual gRNAs, we introduced 
individual gRNAs to determine whether their rate of GFP loss correlated with their activity 
in the pooled MERA screen. These gRNAs fell within several of the functional categories 
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including UREs and neighboring promoters (Fig. 2a highlighted in grey, Fig. 2b). We 
confirmed significantly increased GFP loss in 29/30 gRNAs from these screens as compared 
to five similarly located control gRNAs (Fig. 2b). Altogether, we conclude that MERA has a 
low false positive rate.
We next sought to determine the false negative rate of MERA. As opposed to ORF-targeting 
screens in which all gRNAs are assumed to be equivalently likely to induce frameshift 
mutations that inactivate gene function, we find that regulatory mutations induce more 
variable phenotypes with regards to gene expression (see Supplementary Discussion). In our 
individual follow-up assays, we find that gRNAs targeting the GFP ORF induce GFP loss in 
>90% of cells, those targeting promoter regions induce GFP loss in 20–40% of cells, those 
targeting distal regulatory elements induce GFP loss in 5–40% of cells, while negative 
controls induce GFP loss in <2% of cells (Fig. 2b). We assert that this phenotypic diversity 
results from the wide spectrum of mutations at target sites, which are differentially likely to 
disrupt functional regulatory elements such as transcription factor binding sites. We confirm 
this hypothesis in several cases by performing functional motif discovery, described later in 
the text.
To assess the false-negative rate of MERA gRNAs, we examined regions in our data with 
strong likelihood to induce GFP loss. We found 10/10 GFP-targeting gRNAs in all 4 GFP 
lines are highly enriched in GFPneg cells (Fig. 2d, Fig. 3c). Additionally, 67/83 (81%) 
gRNAs that target the first 700bp of the Rpp25 open-reading frame are highly enriched in 
GFPneg cells. In a 500bp around the Tdgf1 promoter region, 48/59 (81%) of gRNAs induce 
GFP loss in multiple replicates (Supplementary Fig. 4f). Thus, we find that a high 
percentage of gRNAs expected to have an effect on gene expression are enriched in GFPneg 
cells. It is unclear whether the 20% of gRNAs in these regions that do not induce GFP loss 
are false negatives or true negatives, as their mechanism of inducing GFP loss is not as direct 
as when the GFP ORF itself is targeted. However, even if this appreciable percentage of 
individual gRNAs are false negatives, it does not impair the ability of MERA to determine 
required regulatory regions, as the high density of gRNAs in a region (~1 per 8 bp) allows 
highly reproducible resolution at the level of 100–1000 bp (Fig. 2c, 3b). We then asked if 
annotated regulatory regions are necessary for gene function. An appreciable percentage of 
gRNAs induce significant GFP loss at 9/9 of Tdgf1 predicted enhancers (+/− 20kb around 
Tdgf1) and 6/7 of predicted Zfp42 enhancers (−21 to +45kb around Zfp42). (Supplementary 
Tables 2,3). However, there is substantial heterogeneity in the percentage of gRNAs within 
an enhancer that induce GFP loss, and some DNase-hypersensitive sites without enhancer 
histone modifications contain a high fraction of GFP loss-inducing gRNAs (Supplementary 
Tables 2,3), indicating that enhancer histone modifications do not entirely predict required 
regulatory regions. We cannot rule out that certain regions may suffer from systematic 
inefficiencies in gRNA targeting.
Gene regulatory trends emerging from MERA screens
Our MERA results revealed that Tdgf1, Nanog, Rpp25 and Zfp42 have different regulatory 
architectures (Fig. 2, Fig. 3, Supplementary Figs 5,6,10). All regulatory regions within 20kb 
of the Nanog promoter were associated with clusters of highly enriched gRNAs, and 20% to 
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40% of the tested gRNAs in predicted enhancers and DNase-I hotspots proximal to Nanog 
resulted in GFPneg cells (Supplementary Fig. 10c). In contrast, the Rpp25 gene shows a 
dense concentration of significant gRNAs at its promoter and short ORF region. Other 
proximal regulatory regions of Rpp25 had 12% of tested gRNAs resulting in GFPneg cells 
(Supplementary Fig. 10d). Tdgf1 shows a similar trend to Nanog with dense clusters of 
significant gRNA in the proximal regulatory regions (Fig. 2a,d). UREs were also seen in cis-
regulatory regions near Rpp25 (Supplementary Fig. 10b). In Nanog, a distal ChIA-Pet region 
>92 mB away showed several strongly enriched gRNAs whereas three other distal ChIA-Pet 
regions showed no strongly enriched gRNAs (Supplementary Fig. 10a), indicating that 
MERA is capable of measuring the functionality of long-distance chromatin interactions.
One observation common to all genes is the participation of the promoters of other genes in 
regulation. In some cases these gene promoters are several million bases away. Examples of 
foreign promoter involvement can be seen in the case of Lrrc2 promoter in Tdgf1 (Fig. 2a,d), 
Mirc35hg in Nanog (Supplementary Fig. 10a), Scamp5 and Cox5a in Rpp25 
(Supplementary Fig. 10b). Previous studies have documented the existence of dual property 
elements40 that can act as either promoter or enhancer in different cellular contexts. 
Additionally, it is known that neighboring promoters often interact with each other41 and 
that neighboring gene expression is often coordinated42. Here we observe that active 
promoters may coordinate gene expression patterns of neighboring genes by functioning as 
enhancers within the same cellular context.
Functional motif discovery to examine MERA-predicted regulatory regions
The second phase of MERA uses functional motif discovery to identify the causal elements 
governing expression at MERA screen hits. Because Cas9 induces random mutations, a pool 
of mESCs treated with Cas9 and a single gRNA will contain thousands of distinct mutant 
genotypes centered on the gRNA cleavage site. Recently, TAL effector nucleases have been 
used to derive functional footprints of regulatory DNA43. We hypothesized that we could 
pinpoint DNA sequence motif(s) that cause GFP loss by identifying sequence features that 
consistently differ between thousands of GFPpos and GFPneg genotypes at a given site (Fig. 
4a). Functional motif discovery proceeds by performing individual Cas9-mediated mutation 
by a selected gRNA, obtaining thousands of genotypes from both GFPpos and 
GFPmedium/neg cells by high-throughput sequencing, and then summarizing the observed 
genotypes as motifs that reveal which bases are important for gene expression (Fig. 4a, 
Supplementary Methods). Using the differences in fractions of genotypes at positions along 
the gRNA, we defined a base-level importance score that was independent of the cutting 
biases of the gRNA and built a Random Forest44 classifier to gauge the accuracy of 
distinguishing GFPneg or GFPpos genotypes using base-level features (Supplementary 
Methods).
We first tested to see if functional motif discovery in Tdgf1 and Zfp42 enhancer regions 
would permit us to classify genotypes held-out of initial algorithmic training as GFPneg or 
GFPpos. We selected two overlapping gRNAs for functional motif discovery in a Tdgf1 
proximal enhancer that overlapped binding sites for the key mESC transcription factors 
Stat3, Sox2 and Tcfcp2lI, of which Stat3 is the only factor with a direct binding site. We 
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were able to classify held out genotypes with an area under the curve (AUC) of 0.81 (Fig. 
4c), and observed an enrichment of the bases for the Stat3 motif30 in both the left and right 
paired end reads (Fig. 4d, Supplementary Fig. 12e). We achieved similar success at Zfp42 
enhancer sites, identifying required bases around Nrf1 and p300 binding sites 
(Supplementary Fig. 13).
We next applied functional motif discovery to two gRNAs in a URE ~12 kb downstream of 
the Tdgf1 transcript (Fig. 5a). We obtained high classification accuracy for held out 
genotypes from both gRNAs (AUC 0.81 and 0.76, Fig. 5b, Supplementary Fig. 15c), and we 
observed blocks of consecutive bases whose deletion correlated with GFP loss (Fig. 5c-d, 
Supplementary Fig. 15d-e), suggesting focal regions of the genome that are required for 
URE function. Altogether, we conclude that functional motif discovery is a valuable method 
for ascertaining which bases at MERA-identified regulatory regions are required for gene 
expression. In enhancer regions, these bases correspond to known binding motifs, and in 
UREs, we identify blocks of bases which are required for gene expression.
We then used homologous recombination to validate that the Tdgf1 enhancer and URE 
regulatory elements are truly required for gene expression in the third phase of MERA. We 
used flanking gRNAs to induce short (>100 bp) deletions in two regions predicted to induce 
GFP loss by our MERA screen, one in the Tdgf1 enhancer and one at a URE. As expected, a 
subset of cells lost GFP expression, and we obtained clonal GFPneg lines containing the 
deletion genotype (Fig. 6a,b). We then used homology-directed repair to restore the wild-
type genotype in these cells, finding at each site that a large percentage of cells reverted to a 
GFPpos state (Fig. 6b). We replicated this experiment in wildtype cells without a Tdgf1–GFP 
allele, finding that clonal deletion cells lost Tdgf1 RNA expression, and clonal repaired lines 
restored Tdgf1 expression (Fig. 6c). This robust and straightforward relationship between 
local genotype and GFP expression provides compelling evidence that the local DNA 
sequence at a URE is required for Tdgf1 expression.
Discussion
MERA offers an unbiased, high-resolution approach to directly interrogate the function of 
the regulatory genome. It not only provides a survey of required cis-regulatory elements, but 
also enables functional motif discovery to dissect the precise nature of identified regulatory 
elements. We find evidence that neighboring gene promoters as well as unmarked regulatory 
elements (UREs) that are not associated with conventionally expected DNase 
hypersensitivity and histone mark features play unexpectedly large roles in controlling gene 
expression. This observation reinforces the importance of direct perturbation analysis to 
definitively characterize genome function, as we observe that correlative genome annotation 
does not fully predict regulatory requirement.
While we do not yet have definitive data as to the function of UREs, we find that a URE 
downstream of the Tdgf1 gene is highly sensitive to base substitution at a string of 
consecutive bases, suggesting that its DNA sequence is crucial to its regulatory activity. 
Furthermore, we find the first half of this URE to be highly conserved (phastcons 
score>0.85, Supplementary Fig. 14e) indicating potential functional significance of the 
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genomic region. Consistent with these data, UREs may be RNA templates, elements bound 
by uncharacterized protein factors, or spacers where their precise base sequence is of 
secondary importance. We cannot exclude the possibility that UREs are only active in a 
cellular subpopulation and thus conventionally expected DNase hypersensitivity and histone 
mark features are not detected when the entire cellular population is assayed.
We designed our gRNA libraries to target a mix of previously annotated and unannotated 
cis-regulatory regions, and thus we did not uniformly tile the proximal regions of any of 
these genes. Therefore, we cannot estimate the frequency of UREs, and we expect that 
future MERA screens with even more extensive coverage at more loci will elucidate how 
pervasive UREs and neighboring gene promoters are in the regulatory architecture of the 
genome.
MERA is complementary to high-throughput reporter assays, and future experiments 
performing both approaches should provide insight into the degree of concordance between 
necessary and sufficient gene regulatory elements. MERA also enables quantitative 
assessment of the relative effects of distinct cis-regulatory elements on gene expression and 
could potentially provide insights into how regulatory regions combine to achieve desired 
levels of expression. Extending MERA to explore how changes in individual cis-regulatory 
elements alter gene networks will aid our understanding of how cis-regulatory variants lead 
to human disease. We expect that the direct interrogation of variant locations discovered in 
genome-wide association studies by MERA will provide a rapid way to screen such variants 
for function in relevant cell types.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
References
1. Jenuwein T, Allis CD. Translating the histone code. Science. 2001; 293:1074–1080. [PubMed: 
11498575] 
2. Bernstein BE, et al. A bivalent chromatin structure marks key developmental genes in embryonic 
stem cells. Cell. 2006; 125:315–326. [PubMed: 16630819] 
3. Rada-Iglesias A, et al. A unique chromatin signature uncovers early developmental enhancers in 
humans. Nature. 2011; 470:279–283. [PubMed: 21160473] 
4. Heintzman ND, et al. Histone modifications at human enhancers reflect global cell-type-specific 
gene expression. Nature. 2009; 459:108–112. [PubMed: 19295514] 
5. Creyghton MP, et al. Histone H3K27ac separates active from poised enhancers and predicts 
developmental state. Proceedings of the National Academy of Sciences of the United States of 
America. 2010; 107:21931–21936. [PubMed: 21106759] 
6. Melnikov A, et al. Systematic dissection and optimization of inducible enhancers in human cells 
using a massively parallel reporter assay. Nature biotechnology. 2012; 30:271–277.
7. Arnold CD, et al. Genome-wide quantitative enhancer activity maps identified by STARR-seq. 
Science. 2013; 339:1074–1077. [PubMed: 23328393] 
8. Patwardhan RP, et al. Massively parallel functional dissection of mammalian enhancers in vivo. 
Nature biotechnology. 2012; 30:265–270.
9. Fullwood MJ, et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature. 
2009; 462:58–64. [PubMed: 19890323] 
Rajagopal et al. Page 9
Nat Biotechnol. Author manuscript; available in PMC 2016 November 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
10. Lieberman-Aiden E, et al. Comprehensive mapping of long-range interactions reveals folding 
principles of the human genome. Science. 2009; 326:289–293. [PubMed: 19815776] 
11. Simonis M, et al. Nuclear organization of active and inactive chromatin domains uncovered by 
chromosome conformation capture-on-chip (4C). Nature genetics. 2006; 38:1348–1354. [PubMed: 
17033623] 
12. Dostie J, et al. Chromosome Conformation Capture Carbon Copy (5C): a massively parallel 
solution for mapping interactions between genomic elements. Genome research. 2006; 16:1299–
1309. [PubMed: 16954542] 
13. Kwasnieski JC, Fiore C, Chaudhari HG, Cohen BA. High-throughput functional testing of 
ENCODE segmentation predictions. Genome research. 2014; 24:1595–1602. [PubMed: 
25035418] 
14. Jinek M, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial 
immunity. Science. 2012; 337:816–821. [PubMed: 22745249] 
15. Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013; 339:819–
823. [PubMed: 23287718] 
16. Mali P, et al. RNA-guided human genome engineering via Cas9. Science. 2013; 339:823–826. 
[PubMed: 23287722] 
17. Jinek M, et al. RNA-programmed genome editing in human cells. eLife. 2013; 2:e00471. 
[PubMed: 23386978] 
18. Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK. Improving CRISPR-Cas nuclease specificity 
using truncated guide RNAs. Nature biotechnology. 2014; 32:279–284.
19. Cho SW, et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases 
and nickases. Genome research. 2014; 24:132–141. [PubMed: 24253446] 
20. Gilbert LA, et al. CRISPR-mediated modular RNA-guided regulation of transcription in 
eukaryotes. Cell. 2013; 154:442–451. [PubMed: 23849981] 
21. Fu Y, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human 
cells. Nature biotechnology. 2013; 31:822–826.
22. Kleinstiver BP, et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature. 
2015; 523:481–485. [PubMed: 26098369] 
23. Cradick TJ, Fine EJ, Antico CJ, Bao G. CRISPR/Cas9 systems targeting beta-globin and CCR5 
genes have substantial off-target activity. Nucleic acids research. 2013; 41:9584–9592. [PubMed: 
23939622] 
24. Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 
system. Science. 2014; 343:80–84. [PubMed: 24336569] 
25. Shalem O, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014; 
343:84–87. [PubMed: 24336571] 
26. Zhou Y, et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in 
human cells. Nature. 2014; 509:487–491. [PubMed: 24717434] 
27. Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera Mdel C, Yusa K. Genome-wide recessive genetic 
screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nature biotechnology. 
2014; 32:267–273.
28. Chen S, et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. 
Cell. 2015; 160:1246–1260. [PubMed: 25748654] 
29. Arbab M, Srinivasan S, Hashimoto T, Geijsen N, Sherwood Richard I. Cloning-free CRISPR. Stem 
Cell Reports. 
30. Young RA. Control of the embryonic stem cell state. Cell. 2011; 144:940–954. [PubMed: 
21414485] 
31. Yue F, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 2014; 
515:355–364. [PubMed: 25409824] 
32. Singh AM, Hamazaki T, Hankowski KE, Terada N. A heterogeneous expression pattern for Nanog 
in embryonic stem cells. Stem cells. 2007; 25:2534–2542. [PubMed: 17615266] 
33. Rajagopal N, et al. RFECS: a random-forest based algorithm for enhancer identification from 
chromatin state. PLoS Comput Biol. 2013; 9:e1002968. [PubMed: 23526891] 
Rajagopal et al. Page 10
Nat Biotechnol. Author manuscript; available in PMC 2016 November 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
34. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 
489:57–74. [PubMed: 22955616] 
35. John S, et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. 
Nature genetics. 2011; 43:264–268. [PubMed: 21258342] 
36. Sherwood RI, et al. Discovery of directional and nondirectional pioneer transcription factors by 
modeling DNase profile magnitude and shape. Nature biotechnology. 2014; 32:171–178.
37. Guo Y, Mahony S, Gifford DK. High resolution genome wide binding event finding and motif 
discovery reveals transcription factor spatial binding constraints. PLoS computational biology. 
2012; 8:e1002638. [PubMed: 22912568] 
38. Tsai SQ, et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas 
nucleases. Nature biotechnology. 2015; 33:187–197.
39. Dixon JR, et al. Topological domains in mammalian genomes identified by analysis of chromatin 
interactions. Nature. 2012; 485:376–380. [PubMed: 22495300] 
40. Leung D, et al. Integrative analysis of haplotype-resolved epigenomes across human tissues. 
Nature. 2015; 518:350–354. [PubMed: 25693566] 
41. Li G, et al. Extensive promoter-centered chromatin interactions provide a topological basis for 
transcription regulation. Cell. 2012; 148:84–98. [PubMed: 22265404] 
42. Woo YH, Walker M, Churchill GA. Coordinated expression domains in mammalian genomes. PloS 
one. 2010; 5:e12158. [PubMed: 20805879] 
43. Vierstra J, et al. Functional footprinting of regulatory DNA. Nature methods. 2015
44. Breiman L. Random Forests. Machine Learning. 2001; 45:5–32.
Rajagopal et al. Page 11
Nat Biotechnol. Author manuscript; available in PMC 2016 November 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Multiplexed editing regulatory assay (MERA)
(a) In MERA, a genomically integrated dummy gRNA is replaced with a pooled library of 
gRNAs through CRISPR/Cas9-based homologous recombination such that each cell 
receives a single gRNA. Guide RNAs are tiled across the cis-regulatory regions of a GFP-
tagged gene locus, and cells are flow cytometrically sorted according to their GFP 
expression levels. Deep sequencing on each population is used to identify gRNAs 
preferentially associated with partial or complete loss of gene expression. (b) Zfp42GFP 
mESCs express uniformly strong GFP. After bulk gRNA integration, a subpopulation of 
Rajagopal et al. Page 12
Nat Biotechnol. Author manuscript; available in PMC 2016 November 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
cells lose partial or complete GFP expression. These cells are flow cytometrically isolated 
for deep sequencing. (c,d) Bulk reads for gRNAs are highly correlated between replicates of 
(c) Tdfg1 or (d) Zfp42, indicating consistent and replicable integration rates.
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Figure 2. MERA enables systematic identification of required cis-regulatory elements for Tdgf1
(a) A genomic view the Tdgf1 proximal regulatory region showing in track order (i) the 
location of gRNAs that did not result in GFP loss, (ii) enriched gRNAs in GFPneg cells (red), 
(iii) enriched gRNAs in GFPmedium cells (green), (iv) annotated genes, (v) predicted 
enhancers (green=weak, red=strong), (vi) DNase-I hotspot regions, (vii) transcription factor 
binding density based on ChIP-seq data, (vii) H3K4me3 ChIP-seq data. Several active 
regulatory elements coincide with dense clusters of overlapping gRNAs. A large number of 
gRNA significantly enriched in GFPneg population are also observed in regions devoid of 
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regulatory element features (UREs). Genomic regions of interest are shaded, annotated 
above the plot, and described in further detail in the text. (b) Individual validation of specific 
gRNAs detected as enriched in the GFPneg population in the MERA assay using the self-
cloning CRISPR system. The proportion of cells undergoing GFP loss upon incorporation of 
a particular gRNA divided by the proportion of cells undergoing GFP loss upon 
incorporation of GFP-targeting positive control gRNA are plotted against the actual genomic 
location of the gRNA. Negative controls or gRNA showing no reads in either GFPneg and 
GFPmedium populations are highlighted in red. (c) Correlation of gRNAs significantly 
enriched in the GFPneg population in fixed size bins varying from 100bp to 1kb for 
biological replicates in Tdgf1 (d) Fraction of GFPneg enriched gRNA among the different 
functional genomic categories surrounding the Tdgf1 gene.
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Figure 3. MERA enables systematic identification of required cis-regulatory elements for Zfp42
(a) A genomic view the Zfp42 proximal regulatory region showing in track order (i) the 
location of gRNAs that did not result in GFP loss, (ii) enriched gRNAs in GFPneg cells (red), 
(iii) enriched gRNAs in GFPmedium cells (green), (iv) annotated genes, (v) predicted 
enhancers (green=weak, red=strong), (vi) DNase-I hotspot regions, (vii) transcription factor 
binding density based on ChIP-seq data, (vii) H3K4me3 ChIP-seq data. Several active 
regulatory elements coincide with dense clusters of overlapping gRNAs. Genomic regions of 
interest are shaded, annotated above the plot, and described in further detail in the text. (b) 
Correlation of gRNAs significantly enriched in the GFPneg population in fixed size bins 
varying from 100bp to 1kb for biological replicates in Tdgf1. c.) Fraction of GFPneg 
enriched gRNA among the different functional genomic categories surrounding the Tdgf1 
gene.
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Figure 4. Functional motif discovery analysis of region-specific mutant genotypes at enhancers 
reveals required regulatory motifs
(a) A schematic of the procedure involved in finding mutations induced by a particular 
gRNA (b) Plot showing the genomic regions surrounding two gRNAs at a proximal Tdgf1 
enhancer region (gRNAs are shaded) showing overlap with DNase-I hotspot and predicted 
enhancer regions, and transcription factor binding sites Stat3, Tcfcp2l1 and Sox2. (c) ROC 
curve for fivefold classification of GFPneg and GFPpos genotypes using mutations within 
−20 to +20bp of the gRNA along left and right paired end reads as features. (d) Motif logo 
for region mutated by gRNAs with base scores computed as log-ratios of the hellinger 
distance of the GFPneg genotypes at a base to the reference base to the hellinger distance of 
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the GFPpos genotypes at a base to the reference base, caused by Tdgf_gRNA_1 
andTdgf_gRNA_2 along the left paired end read.
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Figure 5. Functional motif discovery analysis of a URE reveals critical base positions involved in 
gene regulation
(a) Plot showing the genomic regions surrounding two gRNAs (gRNAs are shaded) showing 
their absence of active histone modifications, known transcription factor binding, predicted 
enhancers or DNase-I hotspots. (b) Receiver-operating characteristic (ROC) curve for 
fivefold classification of GFPneg and GFPpos genotypes using mutations on the right paired 
end read within –20 to +20bp of Tdgf_URE_gRNA2. Unweighted classification (in blue) 
counts each unique genotype in the test-set only once while weighted classification (red) 
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counts each unique genotype in the test-set as many times as the number of reads assigned to 
it, for calculating sensitivity and specificity. (c) Fraction of unique genotypes in GFPneg and 
GFPpos populations with mutations at bases along the right paired end read reveals pattern of 
cleavage around Tdgf_URE_gRNA2. (d) Motif logo for the region mutated by 
Tdgf_URE_gRNA2 along the right paired end read with base scores computed as log-ratios 
of the hellinger distance of the GFPneg genotypes at a base to the reference base to the 
hellinger distance of the GFPpos genotypes at a base to the reference base.
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Figure 6. Local genotypes at an enhancer and a URE dictate Tdgf1 expression phenotype
(a.) Tdgf1 MERA screen ratio of GFPmedium/neg/bulk reads for each gRNA at an upstream 
enhancer (left) and a downstream URE (right) region. (b) Flow cytometric measurement of 
Tdgf1-GFP expression in clonal cell lines following CRISPR-induced deletion of the shaded 
regions from (a) show loss of GFP (1st and 3rd plots from left). CRISPR-mediated 
homology-directed repair (HDR) back to the wildtype genotype induced robust GFP 
recovery at both loci (2nd and 4th plots from left). c.) Tdgf1 RNA expression in wild-type 
mESCs (left), clonal mESC lines with deletions of the enhancer and URE shaded in (a) (2nd 
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and 3rd from left), and bulk mESC lines following HDR back to the wildtype genotype (4th 
and 5th from left), all normalized to wildtype expression level.
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